Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Radiotherapy is one of the most successful cancer therapies. Here the effect of irradiation on antigen presentation by MHC class I molecules was studied. Cell surface expression of MHC class I molecules was increased for many days in a radiation dose-dependent manner as a consequence of three responses. Initially, enhanced degradation of existing proteins occurred which resulted in an increased intracellular peptide pool. Subsequently, enhanced translation due to activation of the mammalian target of rapamycin pathway resulted in increased peptide production, antigen presentation, as well as cytotoxic T lymphocyte recognition of irradiated cells. In addition, novel proteins were made in response to gamma-irradiation, resulting in new peptides presented by MHC class I molecules, which were recognized by cytotoxic T cells. We show that immunotherapy is successful in eradicating a murine colon adenocarcinoma only when preceded by radiotherapy of the tumor tissue. Our findings indicate that directed radiotherapy can improve the efficacy of tumor immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“irradiation can also increase tumor antigenicity through enriching the pool of antigenic peptides”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Reits et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“folding the HLA-A1 heavy chain with peptides CGI-51(206–215), MSH6(469–478), and F-box protein Fbl7(335–362) and human β2m as described (51).”
BackgroundDNA double-strand breaks: signaling, repair and the cancer connection
Khanna, K. K., & Jackson, S. P. (2001) · Nature Genetics · doi:10.1038/85798 · Cited by 2,455
Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
Schubert, U., Antón, L. C., Gibbs, J., Norbury, C. C., Yewdell, J. W., & Bennink, J. R. (2000) · Nature · doi:10.1038/35008096 · Cited by 1,536
Error-Tolerant Identification of Peptides in Sequence Databases by Peptide Sequence Tags
Mann, M., & Wilm, M. (1994) · Analytical Chemistry · doi:10.1021/ac00096a002 · Cited by 1,468
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
Demaria, S., Ng, B., Devitt, M. L., Babb, J. S., Kawashima, N., Liebes, L., & Formenti, S. C. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.09.012 · Cited by 1,388
Fingar, D. C., & Blenis, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207542 · Cited by 1,247
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
Lee, P. P., Yee, C., Savage, P. A., Fong, L., Brockstedt, D., Weber, J. S., Johnson, D., Swetter, S., Thompson, J., Greenberg, P. D., et al. (1999) · Nature Medicine · doi:10.1038/9525 · Cited by 1,113
Lugade, A. A., Moran, J. P., Gerber, S. A., Rose, R. C., Frelinger, J. G., & Lord, E. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7516 · Cited by 966 · cited 3×
“This is probably not due only to up-regulation of MHC class I expression because mTOR activation will have more general eff ects on protein expression including up-regulation of Fas, ICAM-1 (38), and interferon expression (33, 34).”
Background
Research works printed but not linked: 5
- 2000, Oncology (Huntingt), 14, 741
- 1988, Nippon Igaku Hoshasen Gakkai Zasshi., 48, 1572
- 2000, Anticancer Res., 20, 3375
- 2002, Cancer Res., 62, 1462
- 1991, Cancer Res., 51, 3657
Cited by
Items 901–1,000 of 1,000
Immune checkpoint pathways in glioblastoma: a diverse and evolving landscape
Inocencio, J. F., Mitrasinovic, S., Asad, M., Parney, I. F., Zang, X., & Himes, B. T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1424396 · Cited by 23
Low dose irradiation profoundly affects transcriptome and microRNAme in rat mammary gland tissues
Luzhna, L., & Kovalchuk, O. (2014) · Oncoscience · doi:10.18632/oncoscience.94 · Cited by 22
Li, P., Wang, X., Liu, Z., Liu, H., Xu, T., Wang, H., Gomez, D. R., Nguyen, Q., Wang, L., Teng, Y., et al. (2015) · Clinical Lung Cancer · doi:10.1016/j.cllc.2015.11.008 · Cited by 22
Faè, D. A., Martorelli, D., Mastorci, K., Muraro, E., Col, J. D., Franchin, G., Barzan, L., Comaro, E., Vaccher, E., Rosato, A., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0108 · Cited by 22
The Role of Local Ablative Therapy in Oligometastatic Non-Small-Cell Lung Cancer: Hype or Hope
Bansal, P., Rusthoven, C. G., Boumber, Y., & Gan, G. N. (2016) · Future Oncology · doi:10.2217/fon-2016-0219 · Cited by 22
Lamichhane, P., Amin, N. P., Agarwal, M., & Lamichhane, N. (2018) · Medicines · doi:10.3390/medicines5040114 · Cited by 22
Repurposing Drugs for Cancer Radiotherapy: Early Successes and Emerging Opportunities
Khan, M. K., Nasti, T. H., Buchwald, Z. S., Weichselbaum, R. R., & Kron, S. J. (2019) · The Cancer Journal · doi:10.1097/ppo.0000000000000369 · Cited by 22
Immunity, immunotherapy, and rectal cancer: A clinical and translational science review
Otegbeye, E. E., Mitchem, J. B., Park, H., Chaudhuri, A. A., Kim, H. J., Mutch, M. G., & Ciorba, M. A. (2020) · Translational research · doi:10.1016/j.trsl.2020.12.002 · Cited by 23
Akanda, Z. Z., Neeson, P. J., John, T., Barnett, S. A., Hanna, G. G., Miller, A., Jennens, R. R., & Siva, S. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-1117 · Cited by 22
Lambin, T., Lafon, C., Drainville, R. A., Pioche, M., & Prat, F. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i13.1288 · Cited by 22
Glutamine metabolism and radiosensitivity: Beyond the Warburg effect
Alden, R. S., Kamran, M. Z., Bashjawish, B., & Simone, B. A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1070514 · Cited by 22
Immunomodulation of classical and non-classical HLA molecules by ionizing radiation
Gallegos, C. E., Michelin, S., Dubner, D., & Carosella, E. D. (2016) · Cellular Immunology · doi:10.1016/j.cellimm.2016.04.005 · Cited by 22
Tumor-Induced Immune Suppression
Gabrilovich, D. I., & Hurwitz, A. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-69118-3 · Cited by 22
Buttigliero, C., Allis, S., Tucci, M., Zichi, C., Leone, G., Stefano, R. F. D., Redda, M. G. R., Ricardi, U., Scagliotti, G. V., Maïo, M. D., et al. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.07.010 · Cited by 22
Radiation-Induced Immune Responses from the Tumor Microenvironment to Systemic Immunity
Png, S., Tadepalli, S., & Graves, E. E. (2025) · Cancers · doi:10.3390/cancers17233849 · Cited by 21
Shirasawa, M., Yoshida, T., Matsumoto, Y., Shinno, Y., Okuma, Y., Goto, Y., Horinouchi, H., Yamamoto, N., WATANABE, S.-I. I., Ohe, Y., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.08.028 · Cited by 21
Targeting tumor microenvironment and metastasis in children with solid tumors
Wessel, K. M., & Kaplan, R. N. (2021) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001082 · Cited by 21
Chen, X., Yung, L. L., Tan, P. H., & Bay, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.865554 · Cited by 22
Ji, H., & Zhou, Z. (2022) · Cancers · doi:10.3390/cancers14143505 · Cited by 21
Mukherjee, D., Romano, E., Walshaw, R. C., Zeef, L. A. H., Banyard, A., Kitcatt, S. J., Cheadle, E. J., Tuomela, K., Pendharkar, S., Al-Deka, A., et al. (2023) · OncoImmunology · doi:10.1080/2162402x.2023.2223094 · Cited by 21
Exploring the Molecular Complexity of Medulloblastoma: Implications for Diagnosis and Treatment
Rechberger, J. S., Toll, S. A., Vanbilloen, W. J. F., Daniels, D. J., & Khatua, S. (2023) · Diagnostics · doi:10.3390/diagnostics13142398 · Cited by 21
Radiotherapy-induced Immune Response Enhanced by Selective HDAC6 Inhibition
Noonepalle, S. K. R., Grindrod, S. C., Aghdam, N., Li, X., Gracia-Hernandez, M., Delgado, C. Z., Jung, M., Villagra, A., & Dritschilo, A. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0215 · Cited by 21
Jeon, S. H., Song, C., Eom, K., Kim, I. A., & Js, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316691 · Cited by 21
Intratumoural immunotherapy plus focal thermal ablation for localized prostate cancer
Séguier, D., Adams, E. S., Kotamarti, S., D’Anniballe, V. M., Michael, Z. D., DEIVASIGAMANI, S. R., Olivier, J., Villers, A. A., Hoimes, C. J., & Polascik, T. J. (2023) · Nature Reviews Urology · doi:10.1038/s41585-023-00834-y · Cited by 21
Locally Advanced Lung Cancer: An Optimal Setting for Vaccines and Other Immunotherapies
Iyengar, P., & Gerber, D. E. (2013) · The Cancer Journal · doi:10.1097/ppo.0b013e318292e51a · Cited by 21
CD8+ T Cells in Immunotherapy, Radiotherapy, and Chemotherapy
Wang, W., Green, M. D., Liu, J. R., Lawrence, T. S., & Zou, W. (2017) · Springer eBooks · doi:10.1007/978-3-319-62431-0_3 · Cited by 21
Irradiation to Improve the Response to Immunotherapeutic Agents in Glioblastomas
Nesseler, J. P., Schaue, D., McBride, W. H., Lee, M.-H., Kaprealian, T. B., Niclou, S. P., & Nickers, P. (2018) · Advances in Radiation Oncology · doi:10.1016/j.adro.2018.11.005 · Cited by 21
Vaidya, P., Mehta, A., Ragab, O. M., Lin, S., & In, G. K. (2019) · JAAD Case Reports · doi:10.1016/j.jdcr.2019.06.026 · Cited by 21
Expanding the role of interventional oncology for advancing precision immunotherapy of solid tumors
Kimura, Y., Ghosn, M., Cheema, W., Adusumilli, P. S., Solomon, S. B., & Srimathveeralli, G. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.12.018 · Cited by 21
Ji, X., Jiang, W., Wang, J., Zhou, B., Ding, W., Liu, S., Huang, H., Chen, G., & Sun, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1106644 · Cited by 21
Hadley, J. S. (2007) · Frontiers in bioscience · doi:10.2741/2436 · Cited by 21
Integrating conventional and antibody-based targeted anticancer treatment into immunotherapy
Xu, M. M., Pu, Y., Weichselbaum, R. R., & Fu, Y. (2016) · Oncogene · doi:10.1038/onc.2016.231 · Cited by 21
Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumors
Patel, S. H., Rimner, A., & Cohen, R. B. (2007) · Translational Lung Cancer Research · doi:10.21037/tlcr.2017.03.04 · Cited by 21
Ordóñez, R. M., Henríquez‐Hernández, L. A., Federico, M., Valenciano, A., Pinar, B., Lloret, M., Bordón, E., Rodríguez‐Gallego, C., & Lara, P. C. (2013) · Strahlentherapie und Onkologie · doi:10.1007/s00066-013-0488-x · Cited by 21
Innovative gene engineering strategies to address tumor antigen escape in cell therapy
Chen, Y., Niu, S., Li, Y.-R., & Yang, L. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07259-8 · Cited by 20
Blair, T. C., Baird, J. R., Bambina, S., Kramer, G. F., Gostissa, M., Harvey, C. J., Gough, M. J., & Crittenden, M. R. (2022) · Scientific Reports · doi:10.1038/s41598-022-19256-8 · Cited by 20
Passelli, K., Repáraz, D., Kinj, R., & Herrera, F. G. (2024) · British Journal of Radiology · doi:10.1093/bjr/tqae100 · Cited by 20
Sharon, E., Polley, M. C., Bernstein, M. B., & Ahmed, M. M. (2014) · Radiation Research · doi:10.1667/rr13707.1 · Cited by 20
Development of Tumor Cell-Based Vaccine with IL-12 Gene Electrotransfer as Adjuvant
Remic, T., Serša, G., Uršič, K., Čemažar, M., & Kamenšek, U. (2020) · Vaccines · doi:10.3390/vaccines8010111 · Cited by 20
Knispel, S., Stang, A., Zimmer, L., Lax, H., Gutzmer, R., Heinzerling, L., Weishaupt, C., Pföhler, C., Gesierich, A., Herbst, R. A., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000395 · Cited by 20
Watson, G. A., Doi, J., Hansen, A. R., & Spreafico, A. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14355 · Cited by 20
Cheng, S., Cheadle, E. J., & Illidge, T. (2020) · Cancers · doi:10.3390/cancers12102835 · Cited by 20
Blair, T. C., Alice, A. F., Zebertavage, L., Crittenden, M. R., & Gough, M. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.653625 · Cited by 20
Pembrolizumab in endometrial cancer: Where we stand now (Review)
Aravantinou‐Fatorou, A., Andrikopoulou, Α., Liontos, M., Fiste, O., Georgakopoulou, V., Dimopoulos, M. A., Gavriatopoulou, M., & Zagouri, F. (2021) · Oncology Letters · doi:10.3892/ol.2021.13082 · Cited by 20
Immune checkpoint inhibitors for recurrent endometrial cancer
Mutlu, L., Harold, J. A., Tymon‐Rosario, J., & Santin, A. D. (2022) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2022.2044311 · Cited by 20
Filatenkov, A., Baker, J. B., Müller, A. M. S., Ahn, G., Kohrt, H. E. K., Dutt, S., Jensen, K. P., Dejbakhsh‐Jones, S., Negrin, R. S., Shizuru, J. A., et al. (2014) · Radiation Research · doi:10.1667/rr13471.1 · Cited by 22
Figura, N. B., Oliver, D. E., Mohammadi, H., Martinez, K., Grass, G. D., Hoffe, S. E., Johnstone, P. A. S., & Frakes, J. M. (2019) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000634 · Cited by 20
Irradiation conditioning of adjuvanted, autologous cancer cell membrane nanoparticle vaccines
Tuo, Z., He, Q., Zhang, Z., Wang, Y., Sun, J., Wei, Q., Hu, Y., Lovell, J. F., Jin, H., & Yang, K. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.134437 · Cited by 20
Schlom, J., Gulley, J. L., & Hodge, J. W. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm066 · Cited by 20
Self-citationDelineating the Role of PD-1/PD-L1 Blockade in Advanced SCLC
Zimmermann, S., & Peters, S. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.05.042 · Cited by 20
Xu, Y., Chen, J., Qiu, Y., & Du, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1619946 · Cited by 19
Overcoming Immune Resistance With Radiation Therapy in Prostate Cancer
Mulvey, A., Muggeo-Bertin, E., Berthold, D., & Herrera, F. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.859785 · Cited by 19
Photon- and Proton-Mediated Biological Effects: What Has Been Learned?
Jumaniyazova, E. D., Смык, Д., Vishnyakova, P., Fatkhudinov, T., & Gordon, K. B. (2022) · Life · doi:10.3390/life13010030 · Cited by 19
Ababneh, H., Ng, A. K., Frigault, M. J., Abramson, J. S., Johnson, P. C., Jacobson, C. A., & Patel, C. G. (2023) · Haematologica · doi:10.3324/haematol.2023.282804 · Cited by 19
Theranostic role of 89Zr- and 177Lu-labeled aflibercept in breast cancer
Yang, Q. E., Chen, Z., Qiu, Y., Huang, W., Wang, T., Song, L., Sun, X., Li, C., Xu, X., & Kang, L. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06575-9 · Cited by 19
Galati, F., Marra, A., Cicciarelli, F., Pasculli, M., Maroncelli, R., Rizzo, V., Moffa, G., & Pediconi, F. (2024) · La radiologia medica · doi:10.1007/s11547-024-01769-z · Cited by 19
Taha, Z., Crupi, M. J. F., Alluqmani, N., MacKenzie, D., Vallati, S., Whelan, J. T., Fareez, F., Alwithenani, A., Petryk, J., Chen, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51498-0 · Cited by 19
Lind, H., Hall, S. C., Strait, A. A., Goon, J. B., Aleman, J., Chen, S. M. Y., Karam, S. D., Young, C. D., Wang, J. H., & Wang, J. H. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217347 · Cited by 19
“Hit the primary”: A paradigm shift in the treatment of metastatic prostate cancer?
Arcangeli, S., Zilli, T., Bari, B. D., & Alongi, F. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.08.023 · Cited by 19
Combining immunotherapy with radiation for the treatment of glioblastoma
Chow, K. K. H., Hara, W. Y., Lim, M. K., & Li, G. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1762-9 · Cited by 19
Yu, Z., Tan, Z., Lee, B. K., Tang, J., Wu, X., Cheung, K., Lo, N. T. L., Man, K., Liu, L., & Chen, Z. (2015) · Oncotarget · doi:10.18632/oncotarget.5856 · Cited by 19
Owyong, M., Hosseini-Nassab, N., Efe, G., Honkala, A. T., van den Bijgaart, R. J. E., Plaks, V., & Smith, B. R. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.10.001 · Cited by 19
A translational concept of immuno-radiobiology
Lippitz, B. E., & Harris, R. A. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.06.001 · Cited by 19
Yu, J., Shao, B., Luo, M., Du, W., Nie, W., Yang, H. J., & Wei, X. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.11.018 · Cited by 19
Bassanelli, M., Ricciuti, B., Giannarelli, D., Cecere, F. L., Roberto, M., Giacinti, S., Barucca, V., Santarelli, M., Ruggeri, E. M., Marchetti, P., et al. (2021) · Tumori Journal · doi:10.1177/03008916211004733 · Cited by 19
PTTG1 knockdown enhances radiation-induced antitumour immunity in lung adenocarcinoma
Chen, Z., Cao, K., Hou, Y., Lu, F., Li, L., Wang, L., Xia, Y., Zhang, L., Chen, H., Li, R., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119594 · Cited by 19
Lei, Q., Sui, J.-D., Fu, J., Luo, H., Shan, J.-J., Tang, L., Wang, Y., & Wu, Y. (2021) · Translational Cancer Research · doi:10.21037/tcr-21-536 · Cited by 19
Qiu, B., Kline, C., & Mueller, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.674596 · Cited by 19
Overcoming Resistance to Immunotherapy in Head and Neck Cancer Using Radiation: A Review
Hui, C., Chau, B., Gan, G., Stokes, W. A., Karam, S. D., & Amini, A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.592319 · Cited by 19
Interaction Between Modern Radiotherapy and Immunotherapy for Metastatic Prostate Cancer
Ollivier, L., Labbé, M., Fradin, D., Potiron, V. A., & Supiot, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.744679 · Cited by 19
Combination immunotherapy for pancreatic cancer: challenges and future considerations
Gössling, G. C. D. L., Zhen, D. B., Pillarisetty, V. G., & Chiorean, E. G. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2022.2120471 · Cited by 19
Radiation-Induced Immune Modulation
Drake, C. G. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8044-1_12 · Cited by 19
Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer
Puri, S., Shafique, M. R., & Gray, J. E. (2018) · Current Treatment Options in Oncology · doi:10.1007/s11864-018-0556-7 · Cited by 19
Kamatham, S., Shahjehan, F., & Kasi, P. M. (2019) · Current Colorectal Cancer Reports · doi:10.1007/s11888-019-00437-z · Cited by 19
Qin, A., Rengan, R., Lee, S. Y., Santana-Dávila, R., Goulart, B. H. L., Martins, R. G., Baik, C. S., Kalemkerian, G. P., Hassan, K. A., Schneider, B. J., et al. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.10.047 · Cited by 19
The microbiota in radiotherapy-induced cancer immunosurveillance
Chen, J., Deutsch, É., Kroemer, G., Galluzzi, L., & Zitvogel, L. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01052-8 · Cited by 19
Dissecting Tertiary Lymphoid Structures in Cancer: Maturation, Localization and Density
Su, G.-L., Zhang, M.-J., Li, H., & Sun, Z. (2025) · Theranostics · doi:10.7150/thno.113940 · Cited by 18
Zhao, X., Li, J., Zheng, L., Yang, Q., Xu, C., Chen, X., Yu, Y., Li, F., Cui, J., & Sun, J. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.786864 · Cited by 18
Molecular Changes in Breast Cancer Induced by Radiation Therapy
Sheva, K., Chowdhury, S. R., Kravchenko‐Balasha, N., & Meirovitz, A. (2024) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2024.03.019 · Cited by 19
Radiation drives tertiary lymphoid structures to reshape TME for synergized antitumour immunity
Li, S., Chen, K., Sun, Z., Chen, M., Pi, W., Zhou, S., & Yang, H. (2024) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2024.27 · Cited by 18
Enhancing the Efficacy of Adoptive Cellular Therapy By Targeting Tumor-InDuced Immunosuppression
Beavis, P. A., Slaney, C. Y., Kershaw, M. H., Neeson, P. J., & Darcy, P. K. (2015) · Immunotherapy · doi:10.2217/imt.15.16 · Cited by 18
Lee, J., Chang, J. S., Roh, M. R., Jung, M., Lee, C., Oh, B. H., Chung, K. Y., Koom, W. S., & Shin, S. J. (2020) · Cancer Research and Treatment · doi:10.4143/crt.2019.598 · Cited by 18
Tackling Resistance to Cancer Immunotherapy: What Do We Know?
Gondhowiardjo, S. A., Handoko, H., Jayalie, V. F., Apriantoni, R., barata, A. R., Senoaji, F., Utami, I. J. W., Maubere, F., Nuryadi, E., & Giselvania, A. (2020) · Molecules · doi:10.3390/molecules25184096 · Cited by 18
Taniguchi, H., Takemoto, S., Ozasa, M., Honda, N., Suyama, T., Umeyama, Y., Dotsu, Y., Nakao, T., Tomohito, K., Gyotoku, H., et al. (2021) · Thoracic Cancer · doi:10.1111/1759-7714.13890 · Cited by 18
Ahn, J. C., Lauzon, M., Luu, M., Friedman, M. L., Kosari, K., Nissen, N. N., Lu, S. C.-L., Roberts, L. R., Singal, A. G., & Yang, J. D. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.261954 · Cited by 18
Mechanisms of Immune Modulation by Radiation
Spina, C. S., & Drake, C. G. (2021) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2021.02.001 · Cited by 18
The molecular basis of immuno-radiotherapy
Koukourakis, I. M., TINIAKOS, D. G., Kouloulias, V., & Zygogianni, A. G. (2022) · International Journal of Radiation Biology · doi:10.1080/09553002.2023.2144960 · Cited by 18
Angiostasis as a way to improve immunotherapy
Vyth‐Dreese, F. A., & Griffioen, A. W. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-08-0552 · Cited by 18
Mikulandra, M., Kobeščak, A., Vérillaud, B., Busson, P., & Glavan, T. M. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0403-7 · Cited by 18
Overcoming malignant cell-based mechanisms of resistance to immune checkpoint blockade antibodies
Ajina, R., Zahavi, D. J., Zhang, Y., & Weiner, L. M. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.005 · Cited by 18
Radiotherapy and radio‐sensitization in H3K27M ‐mutated diffuse midline gliomas
Liu, C., Kuang, S., Wu, L., Cheng, Q., Gong, X., Wu, J., & Zhang, L. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14225 · Cited by 17
He, P., Ma, L., Xu, B., Wang, Y., Li, X., Chen, H., & Li, Y. (2024) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359241266156 · Cited by 17
Hartley, F., Ebert, M. A., & Cook, A. (2025) · Clinical & Translational Immunology · doi:10.1002/cti2.70030 · Cited by 17
Chen, X., Zhang, Q., Luo, Y., Gao, C., Zhuang, X., Xu, G., & Qaio, T. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s116629 · Cited by 17
Ahmed, K. A., Kim, S., & Harrison, L. B. (2017) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2017.01.007 · Cited by 17
Kris, M. G., Finn, C. F., Kordbacheh, T., Chaft, J. E., Luo, J., Tsao, A. S., & Swisher, S. G. (2020) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_280807 · Cited by 17
Diverse Neoantigens and the Development of Cancer Therapies
Srivastava, R. M., Purohit, T. A., & Chan, T. A.-T. (2020) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2019.12.001 · Cited by 17
Targeting Stress-Response Pathways and Therapeutic Resistance in Head and Neck Cancer
Bos, T., Ratti, J. A., & Harada, H. (2021) · Frontiers in Oral Health · doi:10.3389/froh.2021.676643 · Cited by 17
Youshani, A. S., Rowlston, S., O’Leary, C., Forte, G., Parker, H., Liao, A., Telfer, B., Williams, K., Kamaly-Asl, I. D., & Bigger, B. W. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1410-y · Cited by 16
Sakai, S. A., Oyoshi, H., Nakamura, M., Taki, T., Nomura, K., Hojo, H., Hirata, H., Motegi, A., Nakamura, Y., Zenkoh, J., et al. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03088-0 · Cited by 15
“Recently, accumulating evidence has revealed that immune responses and immunological cell death also contribute to the antitumour effect of RT [1, 2].”
Metadata
- Authors
- Reits, E. A., Hodge, J. W., Herberts, C. A., Groothuis, T. A., Chakraborty, M., K.Wansley, E., Camphausen, K., Luiten, R. M., de Ru, A. H., Neijssen, J., Griekspoor, A., Mesman, E., Verreck, F. A., Spits, H., Schlom, J., van Veelen, P., & Neefjes, J. J.
- Affiliations
- The Netherlands Cancer Institute (NL)
- 2Laboratory of Tumor Immunology and Biology
- National Institutes of Health (US)
- 4Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, and Centre for Medical Systems Biology, 2333 2A Leiden, Netherlands
- Leiden University Medical Center (NL)
- ORCID
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-04-24
- Volume
- 203
- Issue
- 5
- Pages
- 1259-1271
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3212727
- OpenAlex
- W2127733313
- Cited by
- 1,737
- References
- 53
- Citations by year
- 2026: 88 · 2025: 116 · 2024: 119 · 2023: 128 · 2022: 149 · 2021: 174 · 2020: 154 · 2019: 118 · 2018: 112 · 2017: 113 · 2016: 78 · 2015: 71 · 2014: 67 · 2013: 62 · 2012: 41
- FWCI
- 10.85
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- radiotherapy, gamma irradiation, MHC class I expression, antigen presentation, protein degradation, mTOR signaling, translation (biology), cytotoxic T lymphocytes, cancer immunotherapy, colon adenocarcinoma
- MeSH terms
- Adenocarcinoma, Animals, Colonic Neoplasms, Dose-Response Relationship, Radiation, Gamma Rays, Humans, Immunotherapy, Mice, Transgenic, Peptides, Protein Kinases, Radiotherapy, T-Lymphocytes, Cytotoxic, Protein Biosynthesis, HLA-A2 Antigen, Gene Expression Regulation, Neoplastic, Antigen Presentation, Mice, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.